drugset / Trial / NCT00911547

The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

NCT00911547

Phase 3 Completed 642 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will investigate the additive effect of montelukast (MK0476) taken along with inhaled beclomethasone versus inhaled beclomethasone alone.

Timeline

Start
1995-03
Primary completion
1996-04
Completion
1996-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Beclomethasone Small molecule 200 ug Inhaled
Subject Montelukast Other / unclassified 10 mg Oral

Indications